Path to a Healthy Sleep with Sleep Apnea Devices

What Causes the sleep apnea?

Sleep apnea is caused by a blockage of the airway, usually when the soft tissue in the back of the throat collapses during sleep. This can be due to anatomical issues such as enlarged tonsils, a large tongue, or a narrow airway. Other risk factors include being overweight, smoking, drinking alcohol, and using certain sedatives or tranquilizers.

Major Growth Influencing Factors:

The global sleep apnea devices market is expected to witness significant growth in the coming years due to the increasing prevalence of sleep apnea and rising awareness of its treatment. The market is driven by the increasing adoption of sleep apnea devices, technological advancements in products, and the rising prevalence of sleep apnea. In addition, the rising healthcare expenditure and the increasing focus on preventive healthcare are also driving the growth of this market.

However, the high cost of sleep apnea devices, lack of reimbursement policies, and the lack of awareness of sleep apnea and its treatment are some of the major factors restraining the growth of this market. Moreover, the increasing number of competitors, the emergence of new technologies, and the potential of digital health solutions are creating opportunities for the growth of the global sleep apnea devices market.

Targeted Audience:

# health care professionals
# sleep researchers
# sleep apnea patients
# device manufacturers, suppliers, and distributors

Recent Developments:

Increasing Awareness of Sleep Apnea: Sleep apnea is increasingly becoming a topic of conversation, both in the medical field and in the public eye. This is leading to a greater awareness of the condition, which will help to increase the demand for sleep apnea devices.

Technological Advancements: Manufacturers of sleep apnea devices are continually innovating and improving their products. This includes the introduction of smarter and more efficient machines, making them easier to use and more comfortable.

FDA Approval of New Devices: The US Food and Drug Administration (FDA) has recently approved several new sleep apnea devices, including the ResMed AirFit P10 and the Philips DreamStation Go. These devices offer a more comfortable and convenient way to treat sleep apnea.

Increasing Demand for Home Sleep Tests: Home sleep tests are becoming more popular, as they are easier to administer and are more affordable than in-lab tests. This is leading to an increased demand for sleep apnea devices.

Growing Home Healthcare Market: The home healthcare market is set to grow significantly in the years to come, due to the rise in aging populations and the increasing demand for more convenient and cost-effective healthcare solutions. This is likely to drive up the demand for sleep apnea devices.

You Can Download the PDF Brochure to get Broader Outlook of This Study..!

End Users:

Based on end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of in the sleep apnea devices market. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR during the forecast period. This is attributed to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

Difference between Traditional Treatments for Sleep Apnea versus Treatments using Advanced Devices:

Traditional treatments for sleep apnea involve the use of lifestyle modifications and medications to reduce the severity of the condition. These treatments focus on helping to reduce the impact of sleep apnea symptoms, such as snoring and difficulty breathing during sleep. Lifestyle modifications may include weight loss, avoiding alcohol and certain medications, and avoiding sleeping on the back. Medications may include nasal decongestants, anti-inflammatory drugs, and stimulants.

Treatments using advanced sleep apnea devices involve the use of specialized equipment to help manage the condition. These devices are designed to help keep the airway open during sleep, allowing the patient to breathe more easily. They may include continuous positive airway pressure (CPAP) devices, mandibular advancement devices (MADs), or a combination of the two. CPAP devices deliver a steady stream of air through a mask that is worn over the nose and/or mouth during sleep. MADs are mouthpieces that are worn during sleep to help keep the jaw forward, opening the airway and allowing for easier breathing.

Read the Detailed Report on “Global Sleep Apnea Devices Industry Growth Dynamics - 2026”, Here..!

Sleep Apnea Devices Market worth $9.9 billion by 2026

 Overview:

This study involved four major activities in estimating the current size of the sleep apnea devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Future Revenue Growth Trends:

The global Sleep Apnea Devices Market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.

Major Growth Boosting Factors:

The massive pool of undiagnosed sleep apnea patients, increasing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market, are the major factors driving the growth of the Sleep Apnea Devices Market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and market have been identified through extensive secondary research.
# The revenues generated from the sleep apnea devices business of leading players have been determined through primary and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation:

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

End Users:

Sleep laboratories & hospitals account for the largest share of the Sleep Apnea Devices Market in 2020. The home care settings/individuals’ segment is expected to grow at the fastest rate during the forecast period.

Based on end users, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the sleep apnea devices market in 2020. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR during the forecast period. This is attributed to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

Recent Developments:

# In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to provide Oventus’ obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers via sleep clinics in the US.

# In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.

# In November 2020, Panthera Dental collaborated with Dentsply Sirona.

# In December 2019, Fisher & Paykel Healthcare signed a USD-1.5-million partnership agreement with Counties Manukau Health (CM Health) to provide funding for clinical research at Middlemore Hospital.

# In March 2019, ResMed acquired HB Healthcare, a home medical equipment provider, which offers sleep and respiratory care devices.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Geographical Growth Scenario:

North America was the largest regional market for the Sleep Apnea Devices Market in 2020

The Sleep Apnea Devices Market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and Rest of the world (Latin America, and the Middle East & Africa). North America was the largest regional market for Sleep Apnea Devices Market in 2020. The large share of the North American market can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

Sleep Apnea Devices Market - Role of Facial Interfaces in Increasing Cpap Compliance Is Expected to Drive Growth

Sleep Apnea Care Market Dynamics:

Driver: Large pool of undiagnosed sleep apnea patients

Although highly prevalent in the elderly, sleep apnea affects people of all ages and is one of the most common sleep disorders across the globe. The health impact of sleep apnea is quite substantial but under-recognized.

Worldwide data suggests that sleep apnea impacts more than 936 million people worldwide, which is nearly 10 times greater than previous estimates (Source: ResMed). In the US alone, around 22 million Americans suffer from obstructive sleep apnea (OSA); of which, 80% of moderate and severe OSA cases are undiagnosed [Source: American Sleep Apnea Association (ASAA)]. In the UK, OSA affects an estimated 1.5 million adults; up to 85% of these cases are undiagnosed or untreated. In countries with huge population bases, such as India and China, the diagnosis rate of OSA is <1% (Source: Press Trust of India, 2017 and China.org.cn).

Restraint: High cost of CPAP machines

In most developed countries, the cost of a CPAP device is either reimbursed or provided by medical insurance companies. The main reason for non-adherence is non-acceptance on the part of the patient, mainly due to the mask causing discomfort or claustrophobia. However, conditions are different in most developing countries, where insurance access is minimal and insurance companies usually do not cover the cost of a CPAP device.

In countries like India, CPAP is not covered by private insurance companies. Only some government employees are able to be reimbursed for CPAP therapy, and that too reimbursement ranges from 30% to 100% depending on the reimbursement rules of various government offices. CPAP is generally an out-of-pocket expense for most of the Indian population. This is a major limiting factor for therapy adoption in these countries.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

Recent Developments in the Global Sleep Apnea Devices Market:

# In 2019, ResMed (US) launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the US with a newly designed nasal cradle cushion that sits just under the wearer’s nose.

# In 2016, Koninklijke Philips (Netherlands) launched its Dream Family solution which comprises of a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app.

End Users:

Home care settings/individuals projected to grow at the highest CAGR in the global sleep apnea devices market during the forecast period

On the basis of end user, the sleep apnea devices market has been segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the market in 2018, while home care settings/individuals end-user segment is projected to grow at the highest CAGR during the forecast period. This high growth is likely driven by factors such as the rising preference for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.

Key Questions Addressed by the Report:

# Which type segment will dominate the sleep apnea devices market in the future?
# Emerging countries have immense opportunities for the growth and adoption of sleep apnea devices, therefore will this scenario continue in the next five years?
# Where will all the advancements in technology offered by various companies take the industry in the mid to long term?
# What are the upcoming alternative therapies and devices related to the same in the Sleep Apnea Care Market?

North America is expected to dominate the sleep apnea devices market during the forecast period

On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Opportunity: Increasing focus on telemedicine and mHealth (mobile health)

Several studies have reported that a main predictive factor for long-term CPAP compliance is patient adherence in the first few weeks of treatment. To improve compliance, support and follow-up during this period must be prompt. Telemedicine offers this kind of assistance since long waiting lists make it difficult to provide such support. Several studies suggest that patients in the telemedicine group expressed high satisfaction with their care. They especially liked the convenience of a live video visit with a sleep doctor.

Obstructive sleep apnea is a highly prevalent chronic condition, and telemedicine could play a vital role in the different phases of its management. In the future, using new devices capable of signal acquisition and analysis is expected to refine obstructive sleep apnea diagnosis; even smartphones’ built-in sensors could offer improved comfort and the possibility of home sleep monitoring. Continuous positive airway pressure titration could be performed with wireless devices, whose parameters can be changed remotely from sleep centers. Finally, the follow-up phase could be specially improved by using remote continuous positive airway-pressure data, self-management platforms, and mobile applications for patient feedback.

Key Players:

Major players operating in the Sleep Apnea Care Market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).